Related Experiment Video
Updated: May 10, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Chronic hyperglycemia inhibits vasoregression in a transgenic model of retinal degeneration
15th Medical Clinic, Faculty of Clinical Medicine, University of Heidelberg, Mannheim, Germany, yuxi.feng@medma.uni-heidelberg.de.
Abstract:
Vasoregression characterizes diabetic retinopathy in animal models and in humans. We have recently demonstrated that vasoregression is earlier initiated in a rat model of ciliopathy-induced retinal neurodegeneration (TGR rat). The aim was to assess the balance between vasoregressive effects of chronic hyperglycemia and photoreceptor degeneration on adult vascular remodelling. The retinas were analyzed at 4 and 9 months after streptozotocin-induced diabetes. Neurodegeneration was determined by quantitation of cell numbers and retinal layer thickness. Vasoregression was assessed by quantitative retinal morphometry in retinal digest preparations. Retinal VEGF levels were measured by ELISA. Glial activation, expression and location of HSP27 and phosphorylated HSP27 were evaluated by immunofluorescence staining. Unexpectedly, the numbers of acellular capillaries were reduced at both time points and led to fewer intraretinal microvascular abnormalities in late stage diabetic TGR. Concomitantly, inner nuclear layers (INLs) in diabetic TGR rats were protected from cell loss at both time points. Consequently, glial activation was reduced, but VEGF level was increased in diabetic TGR retinas. Expressions of HSP27 were upregulated in glia cells in the preserved INL of diabetic TGR. Chronic hyperglycemia preserves the microvasculature in the retinal model of neurodegeneration. Cell preservation in the retinal INL was associated with protective gene regulation. Together, these data indicate that diabetes can induce vasoprotection, in which retinal glia can play a particular role.
Insights
Chronic hyperglycemia surprisingly protected retinal vasculature and neurons in a diabetic rat model. This suggests diabetes may offer vasoprotection, with retinal glia playing a key role.
Area of Science:
- Ophthalmology
- Diabetology
- Neuroscience
Background:
- Diabetic retinopathy involves vasoregression, a process also seen in ciliopathy-induced retinal neurodegeneration.
- Previous studies showed earlier vasoregression in TGR rats with ciliopathy-induced neurodegeneration.
Purpose of the Study:
- To investigate the interplay between chronic hyperglycemia and photoreceptor degeneration on adult vascular remodeling.
- To assess the vasoprotective effects of diabetes in a neurodegenerative retinal model.
Main Methods:
- Streptozotocin-induced diabetes in TGR rats, analyzed at 4 and 9 months.
- Quantitative retinal morphometry for vasoregression assessment.
- Measurement of retinal VEGF levels, glial activation, and HSP27 expression via ELISA and immunofluorescence.
Main Results:
- Reduced acellular capillaries and fewer microvascular abnormalities in diabetic TGR rats.
- Preservation of inner nuclear layers (INLs) from cell loss in diabetic TGR rats.
- Increased VEGF levels and upregulated HSP27 expression in retinal glia of diabetic TGR rats.
Conclusions:
- Chronic hyperglycemia demonstrated a vasoprotective effect in this retinal neurodegeneration model.
- Cell preservation in the INL was linked to protective gene regulation.
- Retinal glia may play a significant role in mediating diabetes-induced vasoprotection.
Related Concept Videos
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Diabetic Nephropathy
Type I Diabetes II: Pathophysiology
Hyperglycemia

